indirubin-3'-monoxime has been researched along with Bile Duct Cancer in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, MY | 1 |
| Li, YZ | 1 |
| Huang, KJ | 1 |
| Huang, HC | 1 |
| Lin, CY | 1 |
| Lee, YR | 1 |
1 other study available for indirubin-3'-monoxime and Bile Duct Cancer
| Article | Year |
|---|---|
Indirubin-3'-oxime suppresses human cholangiocarcinoma through cell-cycle arrest and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cho | 2018 |